Early peanut introduction wins over the HLA-DQA1*01:02 allele in the interplay between environment and genetics

por Manohar, Monali, Nadeau, Kari Christine, Kasowski, Maya
Publicado 2022

Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab

por Andorf, Sandra, Manohar, Monali, Dominguez, Tina, Block, Whitney, Tupa, Dana, Kshirsagar, Rohun A., Sampath, Vanitha, Chinthrajah, R. Sharon, Nadeau, Kari C.
Publicado 2017

Feasibility of sustained response through long-term dosing in food allergy immunotherapy

por Andorf, Sandra, Manohar, Monali, Dominguez, Tina, Block, Whitney, Tupa, Dana, Kshirsagar, Rohun A., Sampath, Vanitha, Chinthrajah, R. Sharon, Nadeau, Kari C.
Publicado 2017

Peanut-specific T cell responses in patients with different clinical reactivity

por Birrueta, Giovanni, Tripple, Victoria, Pham, John, Manohar, Monali, James, Eddie A., Kwok, William W., Nadeau, Kari C., Sette, Alessandro, Peters, Bjoern, Schulten, Véronique
Publicado 2018

CD8(+) T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19

por Mallajosyula, Vamsee, Ganjavi, Conner, Chakraborty, Saborni, McSween, Alana M., Pavlovitch-Bedzyk, Ana Jimena, Wilhelmy, Julie, Nau, Allison, Manohar, Monali, Nadeau, Kari C., Davis, Mark M.
Publicado 2021

Mass cytometry analysis of blood from peanut-sensitized tolerant and clinically allergic infants

por Tursi, Amanda R., Saba, Nicholas K., Dunham, Diane, Manohar, Monali, Peters, Rachel L., Saffery, Richard, Koplin, Jennifer J., Nadeau, Kari C., Neeland, Melanie R., Andorf, Sandra
Publicado 2022

Mass cytometry reveals cellular fingerprint associated with IgE+ peanut tolerance and allergy in early life

por Neeland, Melanie R., Andorf, Sandra, Manohar, Monali, Dunham, Diane, Lyu, Shu-Chen, Dang, Thanh D., Peters, Rachel L., Perrett, Kirsten P., Tang, Mimi L. K., Saffery, Richard, Koplin, Jennifer J., Nadeau, Kari C.
Publicado 2020

HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic success

por Kanchan, Kanika, Shankar, Gautam, Huffaker, Michelle F., Bahnson, Henry T., Chinthrajah, R Sharon, Sanda, Srinath, Manohar, Monali, Ling, Hua, Paschall, Justin E., Toit, George Du, Ruczinski, Ingo, Togias, Alkis, Lack, Gideon, Nadeau, Kari C., Jones, Stacie M., Nepom, Gerald T., Mathias, Rasika A.
Publicado 2022

CD8(+) T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy

por Kaushik, Abhinav, Dunham, Diane, Han, Xiaorui, Do, Evan, Andorf, Sandra, Gupta, Sheena, Fernandes, Andrea, Kost, Laurie Elizabeth, Sindher, Sayantani B., Yu, Wong, Tsai, Mindy, Tibshirani, Robert, Boyd, Scott D., Desai, Manisha, Maecker, Holden T., Galli, Stephen J., Chinthrajah, R. Sharon, DeKruyff, Rosemarie H., Manohar, Monali, Nadeau, Kari C.
Publicado 2022

Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy

por Wright, Benjamin L., Fernandez-Becker, Nielsen Q., Kambham, Neeraja, Purington, Natasha, Tupa, Dana, Zhang, Wenming, Rank, Matthew A., Kita, Hirohito, Shim, Kelly P., Bunning, Bryan J., Doyle, Alfred D., Jacobsen, Elizabeth A., Boyd, Scott D., Tsai, Mindy, Maecker, Holden, Manohar, Monali, Galli, Stephen J., Nadeau, Kari C., Chinthrajah, R. Sharon
Publicado 2018

Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8(+) T cell responses post SARS-CoV-2 infection

por Gao, Fei, Mallajoysula, Vamsee, Arunachalam, Prabhu S., van der Ploeg, Kattria, Manohar, Monali, Röltgen, Katharina, Yang, Fan, Wirz, Oliver, Hoh, Ramona, Haraguchi, Emily, Lee, Ji-Yeun, Willis, Richard, Ramachandiran, Vasanthi, Li, Jiefu, Kathuria, Karan Raj, Li, Chunfeng, Lee, Alexandra S., Shah, Mihir M., Sindher, Sayantani B., Gonzalez, Joseph, Altman, John D., Wang, Taia T., Boyd, Scott D., Pulendran, Bali, Jagannathan, Prasanna, Nadeau, Kari C., Davis, Mark.M.
Publicado 2023

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

por Röltgen, Katharina, Powell, Abigail E., Wirz, Oliver F., Stevens, Bryan A., Hogan, Catherine A., Najeeb, Javaria, Hunter, Molly, Wang, Hannah, Sahoo, Malaya K., Huang, ChunHong, Yamamoto, Fumiko, Manohar, Monali, Manalac, Justin, Otrelo-Cardoso, Ana R., Pham, Tho D., Rustagi, Arjun, Rogers, Angela J., Shah, Nigam H., Blish, Catherine A., Cochran, Jennifer R., Jardetzky, Theodore S., Zehnder, James L., Wang, Taia T., Narasimhan, Balasubramanian, Gombar, Saurabh, Tibshirani, Robert, Nadeau, Kari C., Kim, Peter S., Pinsky, Benjamin A., Boyd, Scott D.
Publicado 2020

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19

por Feyaerts, Dorien, Hédou, Julien, Gillard, Joshua, Chen, Han, Tsai, Eileen S., Peterson, Laura S., Ando, Kazuo, Manohar, Monali, Do, Evan, Dhondalay, Gopal K.R., Fitzpatrick, Jessica, Artandi, Maja, Chang, Iris, Snow, Theo T., Chinthrajah, R. Sharon, Warren, Christopher M., Wittman, Rich, Meyerowitz, Justin G., Ganio, Edward A., Stelzer, Ina A., Han, Xiaoyuan, Verdonk, Franck, Gaudillière, Dyani K., Mukherjee, Nilanjan, Tsai, Amy S., Rumer, Kristen K., Jiang, Sizun, Valdés Ferrer, Sergio Iván, Kelly, J. Daniel, Furman, David, Aghaeepour, Nima, Angst, Martin S., Boyd, Scott D., Pinsky, Benjamin A., Nolan, Garry P., Nadeau, Kari C., Gaudillière, Brice, McIlwain, David R.
Publicado 2021

Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post–COVID-19 syndrome

por Jia, Xiaolin, Cao, Shu, Lee, Alexandra S., Manohar, Monali, Sindher, Sayantani B., Ahuja, Neera, Artandi, Maja, Blish, Catherine A., Blomkalns, Andra L., Chang, Iris, Collins, William J., Desai, Manisha, Din, Hena Naz, Do, Evan, Fernandes, Andrea, Geng, Linda N., Rosenberg-Hasson, Yael, Mahoney, Megan Ruth, Glascock, Abigail L., Chan, Lienna Y., Fong, Sharon Y., Phelps, Maira, Raeber, Olivia, Purington, Natasha, Röltgen, Katharina, Rogers, Angela J., Snow, Theo, Wang, Taia T., Solis, Daniel, Vaughan, Laura, Verghese, Michelle, Maecker, Holden, Wittman, Richard, Puri, Rajan, Kistler, Amy, Yang, Samuel, Boyd, Scott D., Pinsky, Benjamin A., Chinthrajah, Sharon, Nadeau, Kari C.
Publicado 2022

Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination

por Röltgen, Katharina, Nielsen, Sandra C.A., Silva, Oscar, Younes, Sheren F., Zaslavsky, Maxim, Costales, Cristina, Yang, Fan, Wirz, Oliver F., Solis, Daniel, Hoh, Ramona A., Wang, Aihui, Arunachalam, Prabhu S., Colburg, Deana, Zhao, Shuchun, Haraguchi, Emily, Lee, Alexandra S., Shah, Mihir M., Manohar, Monali, Chang, Iris, Gao, Fei, Mallajosyula, Vamsee, Li, Chunfeng, Liu, James, Shoura, Massa J., Sindher, Sayantani B., Parsons, Ella, Dashdorj, Naranjargal J., Dashdorj, Naranbaatar D., Monroe, Robert, Serrano, Geidy E., Beach, Thomas G., Chinthrajah, R. Sharon, Charville, Gregory W., Wilbur, James L., Wohlstadter, Jacob N., Davis, Mark M., Pulendran, Bali, Troxell, Megan L., Sigal, George B., Natkunam, Yasodha, Pinsky, Benjamin A., Nadeau, Kari C., Boyd, Scott D.
Publicado 2022

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19

por Feyaerts, Dorien, Hédou, Julien, Gillard, Joshua, Chen, Han, Tsai, Eileen S., Peterson, Laura S., Ando, Kazuo, Manohar, Monali, Do, Evan, Dhondalay, Gopal K.R., Fitzpatrick, Jessica, Artandi, Maja, Chang, Iris, Snow, Theo T., Chinthrajah, R. Sharon, Warren, Christopher M., Wittman, Richard, Meyerowitz, Justin G., Ganio, Edward A., Stelzer, Ina A., Han, Xiaoyuan, Verdonk, Franck, Gaudillière, Dyani K., Mukherjee, Nilanjan, Tsai, Amy S., Rumer, Kristen K., Jacobsen, Danielle R., Bjornson-Hooper, Zachary B., Jiang, Sizun, Saavedra, Sergio Fragoso, Valdés Ferrer, Sergio Iván, Kelly, J. Daniel, Furman, David, Aghaeepour, Nima, Angst, Martin S., Boyd, Scott D., Pinsky, Benjamin A., Nolan, Garry P., Nadeau, Kari C., Gaudillière, Brice, McIlwain, David R.
Publicado 2022

New-onset IgG autoantibodies in hospitalized patients with COVID-19

por Chang, Sarah Esther, Feng, Allan, Meng, Wenzhao, Apostolidis, Sokratis A., Mack, Elisabeth, Artandi, Maja, Barman, Linda, Bennett, Kate, Chakraborty, Saborni, Chang, Iris, Cheung, Peggie, Chinthrajah, Sharon, Dhingra, Shaurya, Do, Evan, Finck, Amanda, Gaano, Andrew, Geßner, Reinhard, Giannini, Heather M., Gonzalez, Joyce, Greib, Sarah, Gündisch, Margrit, Hsu, Alex Ren, Kuo, Alex, Manohar, Monali, Mao, Rong, Neeli, Indira, Neubauer, Andreas, Oniyide, Oluwatosin, Powell, Abigail E., Puri, Rajan, Renz, Harald, Schapiro, Jeffrey, Weidenbacher, Payton A., Wittman, Richard, Ahuja, Neera, Chung, Ho-Ryun, Jagannathan, Prasanna, James, Judith A., Kim, Peter S., Meyer, Nuala J., Nadeau, Kari C., Radic, Marko, Robinson, William H., Singh, Upinder, Wang, Taia T., Wherry, E. John, Skevaki, Chrysanthi, Luning Prak, Eline T., Utz, Paul J.
Publicado 2021